Overall survival

Progression Free Survival

Local Control Rates

N

2 years OS

(%)

P

2 years PFS

(%)

P

2 years LCR (%)

P

Age

60≥

122

85.9

0.322

68.1

0.435

85.3

0.026

60<

56

73.2

69.3

97.8

Stage

IB2-IIA

21

100

0.027

83.9

0.072

90.9

0.446

IIB-IV

157

79.8

66.5

88.6

Tm diameter

4≥

45

90.9

0.5

79.4

0.021

93.9

0.207

4<

133

79.1

65

87.3

Residual tm

Positive

32

63.5

<0.0005

32.1

<0.0005

69.4

0.001

Negative

146

85.2

74.8

91.9

Presence of residual tumor

Central

13

80.8

0.386

7.7

0.201

7.7

0.580

Peripheral

4

33.3

25

25

Menopausal st.

Pre-

78

84.7

0.864

69.2

0.544

88.5

0.198

Post-

100

79.8

67.8

90.7

Chemotherapy (CHT)

Positive

134

85.3

0.005

90.1

0.040

92.8

0.375

Negative

44

69.1

51.3

91.6

Number of CHT

5≤

80

89

0.759

76

0.588

89.1

0.656

5>

54

77.5

67.8

86.9